CRP and Insulin resistance: Monitoring additional biomarkers to clarify mechanisms, including markers of oxidative stress (e.g., malondialdehyde), inflammation (e.g., high-sensitivity C-reactive protein [hs-CRP]), and insulin resistance (e.g., HOMA-IR), measured at baseline and post-intervention, would also be beneficial.